— Know what they know.
Not Investment Advice

BTAX OTC

Biostax Corp.
1W: +0.0% 1M: +100.0% 3M: +100.0% YTD: +100.0% 1Y: +100.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 60 · $15743 mcap · 47M float · 0.0018% daily turnover · Short 94% of daily vol

Cash Flow Trends

Operating Cash Flow
-$408K +29.9% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$408K +62.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$121K +64.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2022FY2023
— Operating Activities —
Net Income$2M-$4M-$2M
Depreciation & Amort.$639$0$54K
Stock-Based Comp.$0$0$0
Change in Working Capital$1M$702K$848K
Other Non-Cash Items-$3M$2M$1M
Operating Cash Flow-$192K-$582K-$408K
— Investing Activities —
Capital Expenditures$0-$500K$0
Acquisitions (Net)$0$0$0
Investment Purchases$0$0$0
Investment Sales$0$0$0
Other Investing$0$0$0
Investing Cash Flow$0-$500K$0
— Financing Activities —
Net Debt Issuance$197K$315K$138K
Stock Repurchased$0$0$0
Dividends Paid$0$0$0
Other Financing$0$423K$150K
Financing Cash Flow$197K$738K$287K
Net Change in Cash$5K-$343K-$121K
Cash End of Period$10K$150K$30K
Free Cash Flow-$192K-$1M-$408K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms